STERIS plc (NYSE:STE) Shares Sold by Rathbones Group PLC

Rathbones Group PLC trimmed its holdings in STERIS plc (NYSE:STE) by 4.9% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 117,928 shares of the medical equipment provider’s stock after selling 6,068 shares during the period. Rathbones Group PLC’s holdings in STERIS were worth $24,241,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Invesco Ltd. lifted its stake in shares of STERIS by 9.3% in the 4th quarter. Invesco Ltd. now owns 1,022,479 shares of the medical equipment provider’s stock valued at $210,181,000 after purchasing an additional 87,215 shares during the last quarter. Federated Hermes Inc. lifted its position in STERIS by 4.2% in the fourth quarter. Federated Hermes Inc. now owns 328,520 shares of the medical equipment provider’s stock valued at $67,531,000 after buying an additional 13,150 shares during the last quarter. Aviva PLC boosted its stake in STERIS by 55.1% during the fourth quarter. Aviva PLC now owns 84,672 shares of the medical equipment provider’s stock worth $17,405,000 after buying an additional 30,064 shares during the period. Wells Fargo & Company MN increased its position in shares of STERIS by 0.4% during the fourth quarter. Wells Fargo & Company MN now owns 88,360 shares of the medical equipment provider’s stock valued at $18,163,000 after acquiring an additional 394 shares during the last quarter. Finally, Cynosure Group LLC acquired a new stake in shares of STERIS during the fourth quarter valued at about $279,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on STE. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Monday. Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, Stephens reiterated an “overweight” rating and set a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Stock Up 0.0 %

STERIS stock opened at $212.62 on Tuesday. The firm has a market capitalization of $20.89 billion, a P/E ratio of 45.14 and a beta of 0.87. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The stock’s fifty day simple moving average is $223.05 and its 200-day simple moving average is $220.26.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.07%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.